The Hackett Group (HCKT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for May 1, 2025, with key proposals including director elections, an amendment to the stock option plan, an advisory vote on executive compensation, and auditor ratification.
Shareholders can vote online, by mail, or in person, with detailed instructions provided for proxy voting and revocation.
The Board recommends voting in favor of all proposals, emphasizing the importance of shareholder participation.
Voting matters and shareholder proposals
Proposals include electing three directors, amending the 1998 Stock Option and Incentive Plan to increase share limits by 1,950,000, an advisory say-on-pay vote, and ratification of RSM US LLP as auditor.
Shareholders may submit proposals or director nominations for the 2026 meeting within specified deadlines and requirements.
Board of directors and corporate governance
The Board consists of seven members, five of whom are independent; all committees are composed entirely of independent directors.
The Board is divided into three classes, with staggered three-year terms; current nominees are Ted A. Fernandez, Robert A. Rivero, and Alan T.G. Wix.
The Board annually reviews strategy, capital allocation, and human capital plans, and regularly monitors execution and risk.
Stock ownership guidelines require the CEO to hold shares equal to six times base salary.
Policies prohibit hedging and pledging of company securities by directors and officers without approval.
Latest events from The Hackett Group
- Annual meeting to vote on director, stock plan amendment, compensation, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Proxy covers director election, compensation, stock plan amendment, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Q4 2025 beat guidance with SAP and GenAI gains, but margins and EBITDA declined year-over-year.HCKT
Q4 202517 Feb 2026 - Q2 revenue and EPS exceeded guidance, with Gen AI investments and strong cash flow.HCKT
Q2 20242 Feb 2026 - Q3 revenue and adjusted EPS beat guidance; GenAI growth accelerated by LeewayHertz acquisition.HCKT
Q3 202417 Jan 2026 - Q4 results beat guidance on SAP and GenAI strength; GenAI investments to drive 2025 growth.HCKT
Q4 202423 Dec 2025 - Annual meeting to vote on directors, stock plan amendment, compensation, and auditor.HCKT
Proxy Filing2 Dec 2025 - Q2 revenue up 1.6% to $78.9M; Gen AI drives growth, but costs weigh on net income.HCKT
Q2 202523 Nov 2025 - GenAI-fueled growth drove strong Q1 results, despite lower net income from higher expenses.HCKT
Q1 202521 Nov 2025